We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 2.63% | 3.90 | 3.80 | 4.00 | 3.90 | 3.80 | 3.80 | 537,387 | 08:18:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.20 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/10/2024 15:36 | Quite possible. Personally I find it hard to believe that they would not have ran trials in parallel, concurrently or even simultaneously. | supersonico | |
11/10/2024 15:28 | Don’t they require two years of good quality field trials? I think it’s sound to assume 2024 would have been the second year, so presumably now busy analysing the results preparing for a label extension. | kittybiscuits | |
11/10/2024 13:33 | Jun 2023 - Igor Teslenko the President EMEA at Corteva told us in response to a colleagues question on Sunflower seeds; 'Corteva is also running trials in sunflower crops. If extensive testing meets our rigorous requirements and is considered efficient, we will also extend the label to sunflower crops'. | supersonico | |
11/10/2024 13:25 | Will we be seeing Corteva's Blue Sunflower seeds at Euroseeds24? | supersonico | |
11/10/2024 10:55 | Sipcam Oxon SpA announces the acquisition of the distribution assets of Phyteurop S.A. | supersonico | |
11/10/2024 07:37 | EU regulators are more focused on reducing pesticides, not building a future where they aren’t required. dry-Store. unlimitedhangout.com | supersonico | |
11/10/2024 07:25 | MNS, I have no filters applied. Never have, nor will I. Assuming your post was aimed at me. | kittybiscuits | |
11/10/2024 00:46 | Money never sleeps: LIAR. You have me on filter on but one of your myriad ramping IDs. Not on the rest. You avidly check every word I type - it is your obsession. Now FOAD slowly. | neutralpov | |
10/10/2024 20:22 | The filter is working a treat ! | money never sleeps | |
10/10/2024 18:27 | Best option for most of you is Assisted Migration to the Other Side. Optimal for your loved ones..... | neutralpov | |
10/10/2024 14:08 | July 5th RNS has detail of Options. Rather rich ? | alchemy | |
09/10/2024 18:31 | The low insider ownership is a concern given the growth narrative. Does anyone know of shares held in treasury, or stock award plans? | jpegman | |
09/10/2024 18:27 | "Spring coils". It'll be Sambo's coil you'll feel. Apparently costs only a couple of monkeys to ensure a compatible cellmate in many prisons...... | neutralpov | |
09/10/2024 16:31 | Flat line extends. Spring coils. | alchemy | |
09/10/2024 15:44 | Prepare for pump? | timbo_slice | |
09/10/2024 11:39 | 1.22 to 3.57 | money never sleeps | |
09/10/2024 05:19 | 13/8/24: "Sumi Agro Europe, will look to take a notable portion of Germany's biopesticide market share by providing local farmers with a sustainable alternative that performs in much the same way as conventional pesticides." The reference to "notable portion" is interesting as such indicators are normally absent from Eden news releases. I would expect the baseline 3% to be achieved relatively quickly in Germany where there is an established distributor presence and ready market. IMO "notable" probably means >5%, likely 10-20% in short order. A company maker for 2025 and beyond. Edit: Ps. Germany botrytis is a big market: approx. £45m euros pa. Do the math! | money never sleeps | |
08/10/2024 21:01 | STFU, Career multi-ID LIAR and madwoman respectively. | neutralpov | |
08/10/2024 13:28 | As anticipated in 18767 UK ministers are considering allowing the use of a bee-killing pesticide next year despite promising during the election to ban it. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions